Expanded Access Study of UC-MSC in DMD Patients

Summary

The primary objective of this study is to provide UC-MSC treatment to patients with DMD. Secondary objectives will be to further evaluate treatment-related adverse events as well as changes in DMD-related functional testing/assessments, blood laboratories, and inflammation related biomarker levels over time.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications